Showing results (481-490 of 2,330) with videos related to
Sort By:
Pageof 233
Clinical Drug Investigation|January 24, 2014
Effect of steady-state atorvastatin on the pharmacokinetics of a single dose of colchicine in healthy adults under fasted conditionsMatthew W Davis, Suman WasonClinical Drug Investigation|January 10, 2014
Pathway to clozapine use: a comparison between a patient cohort from New Zealand and a cohort from the United KingdomAmanda J Wheeler, Celia L Feetam, Jeff HarrisonClinical Drug Investigation|February 25, 2023
Comparison of Real-World Costs, Healthcare Resource Utilization, and Comorbidity-Related Costs Between Ixekizumab and Secukinumab Among Biologic-Experienced Patients with Psoriasis Over 18 Months in the USAAndrew Blauvelt, Nianwen Shi, Najwa Somani, et al.Clinical Drug Investigation|November 7, 2022
SGLT2 Inhibitors Improve Cardiac Failure by Reducing Whole-Body Oxygen Demand: A HypothesisTakeshi Onoue, Masaharu KataokaClinical Drug Investigation|March 17, 2023
Vericiguat for the Treatment of Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event: A Cost-Effectiveness Analysis from the Perspective of Chinese Healthcare ProvidersXiangyou Yu, Yan Hao, Zhanfang Zhu, et al.Clinical Drug Investigation|March 1, 2023
A Cross-Sectional Study of Tampering in Xtampza ER, an Abuse-Deterrent Formulation of an Extended-Release Opioid, in a Treatment Center PopulationJennifer Jewell, Joshua Black, Matthew Ellis, et al.Clinical Drug Investigation|September 4, 2021
Exploratory Cost-Effectiveness Analysis for Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: Is Linezolid or Daptomycin Favored Over Vancomycin?Michelle Vu, Kenneth J Smith, Sherrie L Aspinall, et al.Clinical Drug Investigation|September 4, 2021
The Impact of Antipsychotic Dose Reduction on Clinical Outcomes and Health Care Resource Use Among Medicare Patients with SchizophreniaMiriam L Zichlin, Fan Mu, Sam Leo, et al.Clinical Drug Investigation|May 25, 2021
Real-world Prescription Pattern, Discontinuation and Costs of Ibrutinib-Naïve Patients with Chronic Lymphocytic Leukemia: An Italian Healthcare Administrative Database AnalysisGiulia Ronconi, Letizia Dondi, Silvia Calabria, et al.Clinical Drug Investigation|August 5, 2021
Tirbanibulin: Topical Treatment for Actinic KeratosisAnna H Dlott, Anthony J Di Pasqua, Sara A SpencerPageof 233